Trials / Recruiting
RecruitingNCT04579588
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 230 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 9 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Flu shot | All participants will receive a single shot of the flu vaccine |
Timeline
- Start date
- 2020-10-29
- Primary completion
- 2028-04-01
- Completion
- 2028-04-01
- First posted
- 2020-10-08
- Last updated
- 2026-03-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04579588. Inclusion in this directory is not an endorsement.